Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
260 participants
INTERVENTIONAL
2013-12-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
beta blocker and amiodarone
The inteventin will be that patients will receive beta blocker Bisoprolol in adjusted dose + Amiodarone per os starting 7 days before coronary by-pass surgery, 200 mg. x 3 tab, followed by 200 mg x 2 tab per os starting on the second postoperative day untill discharge
Amiodarone tab 200 mg x 3
starting 7 days before coronary by-pass surgery per os 200 mg. x 3 tab, followed by 200 mg x 2 tab per os starting on the second postoperative day untill discharge
beta blockers Bisoprolol in adjusted dose
starting 7 days befoe coronary by-pass surgery
beta blocker and statin
The intervention will be that patients will receive beta blocker (Bisoprolol tab in adjusted dose)+ Rosuvastatin 20 mg. x 1 starting 7 days before coronary by-pass surgry untill discharge.
rosuvastatin 20 mg tab x1
starting 7 days before coronary by-pass surgery
beta blockers Bisoprolol in adjusted dose
starting 7 days befoe coronary by-pass surgery
beta blocker
Patients will receive beta blocker (Bisoprolol tab in adjusted dose).
beta blockers Bisoprolol in adjusted dose
starting 7 days befoe coronary by-pass surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amiodarone tab 200 mg x 3
starting 7 days before coronary by-pass surgery per os 200 mg. x 3 tab, followed by 200 mg x 2 tab per os starting on the second postoperative day untill discharge
rosuvastatin 20 mg tab x1
starting 7 days before coronary by-pass surgery
beta blockers Bisoprolol in adjusted dose
starting 7 days befoe coronary by-pass surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart Center BH Tuzla
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enes Osmanović
Mr.med.sc.Dr Enes Osmanovic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart Center BH
Tuzla, TK, Bosnia and Herzegovina
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Enes Osmanović
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0115/09 - (2013)
Identifier Type: -
Identifier Source: org_study_id